Mefuparib Hydrochloride
盐酸美呋哌瑞
Report date: 2025/06/24 09:42:14
NME
Base Information
Drug NameMefuparib Hydrochloride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCisen Pharmaceutical Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesFujian Cancer HospitalConvalife (Shanghai) Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences +[4]
Inactive CompaniesN/A
Active Indications +[12]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A